Paper19787002
Src kinases as therapeutic targets for cancer.
Kim LC and 2 others. Nat Rev Clin Oncol, 2009. Cited by 604 papers, by iCite.
Cite this record
ConductScience Library. Src kinases as therapeutic targets for cancer. Papers, record 19787002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19787002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| src-Family Kinases | Major topic |
| Actins | |
| Animals | |
| Cell Adhesion | |
| Cell Movement | |
| Cell Proliferation | |
| Cell Survival | |
| Clinical Trials as Topic | |
| Crk-Associated Substrate Protein | |
| Drug Evaluation, Preclinical | |
| Enzyme Activation | |
| Extracellular Signal-Regulated MAP Kinases | |
| Focal Adhesion Protein-Tyrosine Kinases | |
| GTPase-Activating Proteins | |
| Gene Expression Regulation, Neoplastic | |
| Genes, ras | |
| Humans | |
| Integrins | |
| MAP Kinase Signaling System | |
| Neoplasm Metastasis | |
| Paxillin | |
| Protein Structure, Tertiary | |
| Receptor Protein-Tyrosine Kinases | |
| Signal Transduction | |
| Time Factors | |
| Transcription Factors |
Source PubMed
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16685275 | Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. | Br J Cancer | 2006 | https://conductscience.org/library/papers/16685275 | PubMed |
| 2 | 16740687 | Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. | Cancer Res | 2006 | https://conductscience.org/library/papers/16740687 | PubMed |
| 3 | 7685273 | Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases. | EMBO J | 1993 | https://conductscience.org/library/papers/7685273 | PubMed |
| 4 | 11553710 | RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. | Mol Biol Cell | 2001 | https://conductscience.org/library/papers/11553710 | PubMed |
| 5 | 12586780 | Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. | Endocrinology | 2003 | https://conductscience.org/library/papers/12586780 | PubMed |
| 6 | 11980666 | Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. | Cancer Res | 2002 | https://conductscience.org/library/papers/11980666 | PubMed |
| 7 | 2469003 | Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. | Mol Cell Biol | 1989 | https://conductscience.org/library/papers/2469003 | PubMed |
| 8 | 10944210 | Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10944210 | PubMed |
| 9 | 12370822 | Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. | Oncogene | 2002 | https://conductscience.org/library/papers/12370822 | PubMed |
| 10 | 16986126 | The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors. | Cancer | 2006 | https://conductscience.org/library/papers/16986126 | PubMed |
| 11 | 11114744 | Role of Src expression and activation in human cancer. | Oncogene | 2000 | https://conductscience.org/library/papers/11114744 | PubMed |
| 12 | 16740741 | The signaling and biological implications of FAK overexpression in cancer. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16740741 | PubMed |
| 13 | 1696179 | Association between the PDGF receptor and members of the src family of tyrosine kinases. | Cell | 1990 | https://conductscience.org/library/papers/1696179 | PubMed |
| 14 | 12615910 | Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. | J Cell Biol | 2003 | https://conductscience.org/library/papers/12615910 | PubMed |
| 15 | 19039322 | Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. | Leukemia | 2009 | https://conductscience.org/library/papers/19039322 | PubMed |
| 16 | 15939018 | The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. | Structure | 2005 | https://conductscience.org/library/papers/15939018 | PubMed |
| 17 | 8339264 | Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. | Cancer Res | 1993 | https://conductscience.org/library/papers/8339264 | PubMed |
| 18 | 12826049 | pp60c-src activation in lung adenocarcinoma. | Eur J Cancer | 2003 | https://conductscience.org/library/papers/12826049 | PubMed |
| 19 | 16507911 | Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. | Am J Pathol | 2006 | https://conductscience.org/library/papers/16507911 | PubMed |
| 20 | 9628900 | Tyrosine phosphorylation and src family kinases control keratinocyte cell-cell adhesion. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9628900 | PubMed |
Cited by407
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 604 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42917883 | A Structural Perspective on Non-covalent Targeting of Conserved Polar Residues in Protein Kinases. | J Med Chem | 2026 | https://conductscience.org/library/papers/42917883 | PubMed |
| 42873192 | Identification of YES1 Inhibitors From Approved Drugs Using a Multimodal Deep Learning Framework. | Mol Inform | 2026 | https://conductscience.org/library/papers/42873192 | PubMed |
| 42614716 | AXL is associated with STAT3 activation in breast cancer. | Mol Clin Oncol | 2026 | https://conductscience.org/library/papers/42614716 | PubMed |
| 42604887 | Unravelling the biological nexus of smoking and postpartum depression: a meta-analysis and functional genomics approach. | Arch Womens Ment Health | 2026 | https://conductscience.org/library/papers/42604887 | PubMed |
| 42599887 | The Src-Family Kinases Hck, Fgr and Lyn Drive Immune Complex-Mediated Glomerulonephritis Through the Syk Tyrosine Kinase. | FASEB J | 2026 | https://conductscience.org/library/papers/42599887 | PubMed |
| 42279348 | ERBB3 Promotes Malignant Behaviors of Endometrial Cancer Cells with Involvement of the Ras-ERK/MAPK Signaling Pathway. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279348 | PubMed |
| 42244989 | Inhibition of SRC prevents bone metastasis of breast cancer by blocking metastatic cell motility and bone directionality. | Theranostics | 2026 | https://conductscience.org/library/papers/42244989 | PubMed |
| 42216210 | 3'UTR regulation of axon translation and optic nerve regeneration. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42216210 | PubMed |
| 42137330 | Ebracteolata cpd B causes ferroptosis and inhibits progression of lung adenocarcinoma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42137330 | PubMed |
| 42126612 | Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells. | Cell Tissue Res | 2026 | https://conductscience.org/library/papers/42126612 | PubMed |
| 41976305 | SFK Inhibition Suppresses EBV-Encoded BART miRNAs and Induces Apoptosis in EBV-Positive Gastric Epithelial Cells. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976305 | PubMed |
| 41972151 | Breast cancer brain metastasis: from molecular insights to therapeutic innovation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41972151 | PubMed |
| 41920357 | Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR. | J Clin Immunol | 2026 | https://conductscience.org/library/papers/41920357 | PubMed |
| 41673457 | Triptolide derivative STP1 ameliorates murine systemic lupus erythematosus via targeting Fyn kinase. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41673457 | PubMed |
| 41671371 | The allosteric landscape of the Src kinase. | Sci Adv | 2026 | https://conductscience.org/library/papers/41671371 | PubMed |
| 41571903 | Incorporation of network pharmacology, molecular docking, survival, density functional theory, and experimental studies to explore the potential key targets of formononetin by TERT-mediated anti-cancer effects in MCF-7 breast cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41571903 | PubMed |
| 41476672 | The Landscape of Potential Targeted Treatments and Chemotherapy Efficacy Biomarkers for TNBC. | Breast Cancer (Dove Med Press) | 2025 | https://conductscience.org/library/papers/41476672 | PubMed |
| 41386885 | Bioinformatics-driven identification of pathogenic missense nsSNPs in the human proto-oncogene SRC and cancer susceptibility. | J Genet Eng Biotechnol | 2025 | https://conductscience.org/library/papers/41386885 | PubMed |
| 41261767 | Unveiling the Anticancer Potential and Molecular Mechanisms of Fangchinoline Against Cholangiocarcinoma Using FTIR Microspectroscopy, In Vitro and In Silico Approaches. | Integr Cancer Ther | 2025 | https://conductscience.org/library/papers/41261767 | PubMed |
| 41194587 | Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41194587 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCAR1 | 9564 | PubTator's text mining | https://conductscience.org/library/genes/9564 | NCBI Gene |
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| PXN | 5829 | PubTator's text mining | https://conductscience.org/library/genes/5829 | NCBI Gene |
| RAB3GAP1 | 22930 | PubTator's text mining | https://conductscience.org/library/genes/22930 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19787002
GET https://conductscience.org/api/papers/v1/19787002/references?page=2